Injection osfa is used for
Reading File
Finding Sources
Searching the Web
Injection OSFA ornidazole sulbactam flucloxacillin amoxicillin uses indications
Searching the Web
OSFA injection India antibiotic combination ornidazole sulbactam flucloxacillin amoxicillin brand
Searching the Web
"OSFA injection" uses indications composition
Searching the Web
OSFA injection ofloxacin sulbactam ampicillin uses
Based on my research, "Injection OSFA" most likely refers to the combination of Ornidazole + Sulbactam + Flucloxacillin + Amoxicillin, a broad-spectrum injectable antibiotic combination used primarily in India. Here is a breakdown:
Injection OSFA - Composition & Uses
Composition
| Letter | Drug | Class |
|---|---|---|
| O | Ornidazole | Nitroimidazole (anti-anaerobic/antiprotozoal) |
| S | Sulbactam | Beta-lactamase inhibitor |
| F | Flucloxacillin | Anti-staphylococcal penicillin |
| A | Amoxicillin | Broad-spectrum aminopenicillin |
Mechanism of Action
- Amoxicillin - inhibits bacterial cell wall synthesis (broad-spectrum: Gram-positive and some Gram-negative)
- Sulbactam - irreversibly inhibits beta-lactamases, protecting amoxicillin from degradation by resistant organisms
- Flucloxacillin - resistant to staphylococcal beta-lactamase; covers MSSA (methicillin-sensitive Staphylococcus aureus)
- Ornidazole - disrupts DNA of anaerobic bacteria and protozoa
This combination provides coverage against:
- Gram-positive organisms (including beta-lactamase-producing staphylococci)
- Many Gram-negative organisms
- Anaerobes
- Some protozoa
Clinical Indications
The combination is used for mixed infections where multiple organism types are suspected, including:
- Skin and soft tissue infections - especially polymicrobial or post-surgical wound infections
- Intra-abdominal infections - peritonitis, abdominal sepsis (anaerobic + aerobic cover)
- Pelvic inflammatory disease (PID) and gynecological infections
- Diabetic foot infections - polymicrobial with anaerobic component
- Post-operative infections
- Orofacial/dental infections - mixed aerobic-anaerobic
- Lower respiratory tract infections with suspected mixed flora
- Bone and joint infections (osteomyelitis)
Why this combination?
The rationale is to cover the full spectrum of pathogens in empirical therapy when culture results are pending - Gram-positives (including MSSA via flucloxacillin), Gram-negatives (amoxicillin-sulbactam), and anaerobes/protozoa (ornidazole) in a single injection.
Note: This is a branded FDC (Fixed-Dose Combination) marketed in India and some other Asian countries. Such multi-drug combinations are not universally approved and are used empirically. Rational antibiotic prescribing principles recommend tailoring therapy to culture sensitivity where possible.
This is a shared conversation. Sign in to Orris to start your own chat.